Page last updated: 2024-11-05

tyramine and Hyperlipoproteinemia Type II

tyramine has been researched along with Hyperlipoproteinemia Type II in 1 studies

Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).

Research Excerpts

ExcerptRelevanceReference
"Lactoferrin was found to inhibit binding and degradation of chylomicron remnants by fibroblasts from subjects with familial hypercholesterolaemia by approximately 50%, implicating involvement of the alpha 2-macroglobulin receptor."1.30Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia. ( Harada-Shiba, M; Kawaguchi, A; Mamo, JC; Smith, D; Yamamoto, A; Yamamura, T; YU, KC, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
YU, KC1
Smith, D1
Yamamoto, A1
Kawaguchi, A1
Harada-Shiba, M1
Yamamura, T1
Mamo, JC1

Other Studies

1 other study available for tyramine and Hyperlipoproteinemia Type II

ArticleYear
Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia.
    Clinical science (London, England : 1979), 1997, Volume: 92, Issue:2

    Topics: Adult; Animals; Carcinogens; Cells, Cultured; Chylomicrons; Cytochalasin D; Fibroblasts; Homozygote;

1997